Oncodesign Appoints Karine Lignel as Group Chief Development Officer
October 25, 2021 at 12:00 pm EDT
ONCODESIGN is announcing the appointment of Karine Lignel as Senior Executive Vice President - Group Chief Development Officer. Karine Lignel, 53 years old, is the former President of Cr?dit Mutuel Innovation (?250 million of equity dedicated to investments in innovative companies), a subsidiary of Cr?dit Mutuel Equity. Over the course of her
career, she has monitored and participated in the development of more than 60 tech companies, mainly in health, including Nanobiotix, Tissium, Maat Pharma, Endodiag, and Global Bioenergies.